These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9891525)

  • 1. 99mTc-MIBI scintigraphy as an indicator of the chemosensitivity of anthracyclines in patients with breast cancer.
    Fujii H; Nakamura K; Kubo A; Enomoto K; Ikeda T; Kubota T; Matsuzaki SW; Kitajima M
    Anticancer Res; 1998; 18(6B):4601-5. PubMed ID: 9891525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative evaluation of the chemosensitivity of breast cancer by means of double phase 99mTc-MIBI scintimammography.
    Fujii H; Nakamura K; Kubo A; Enomoto K; Ikeda T; Kubota T; Matsuzaki SW; Kitajima M
    Ann Nucl Med; 1998 Dec; 12(6):307-12. PubMed ID: 9972367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.
    Kawata K; Kanai M; Sasada T; Iwata S; Yamamoto N; Takabayashi A
    Clin Cancer Res; 2004 Jun; 10(11):3788-93. PubMed ID: 15173086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients.
    Del Vecchio S; Zannetti A; Ciarmiello A; Aloj L; Caracò C; Fonti R; Botti G; D'Aiuto G; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):809-14. PubMed ID: 12029556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
    J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake.
    Fuster D; Muñoz M; Pavia J; Palacín A; Bellet N; Mateos JJ; Martín F; Ortega M; Setoain FJ; Pons F
    Nucl Med Commun; 2002 Jan; 23(1):31-8. PubMed ID: 11748435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the chemosensitivity of lung cancer by 99mTc-hexakis-2-methoxyisobutyl isonitrile SPECT.
    Sasaki M; Kuwabara Y; Ichiya Y; Yoshida T; Nakagawa M; Soeda H; Sugio K; Maehara Y; Masuda K
    J Nucl Med; 1999 Nov; 40(11):1778-83. PubMed ID: 10565770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the heterogeneity of P-glycoprotein expression on technetium-99m-MIBI uptake in breast cancer.
    Kostakoglu L; Ruacan S; Ergün EL; Sayek I; Elahi N; Bekdik CF
    J Nucl Med; 1998 Jun; 39(6):1021-6. PubMed ID: 9627337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
    Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
    Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
    Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.
    Wong M; Evans S; Rivory LP; Hoskins JM; Mann GJ; Farlow D; Clarke CL; Balleine RL; Gurney H
    Clin Pharmacol Ther; 2005 Jan; 77(1):33-42. PubMed ID: 15637529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of drug resistance protein related to Tc-99m MIBI breast imaging.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Anticancer Res; 2000; 20(3B):2021-5. PubMed ID: 10928145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual phase qualitative and quantitative 99mTc-MIBI scintimammography for predicting response to neoadjuvant chemotherapy in breast cancer.
    Zaman MU; Nasir Z; Raza T; Hashmi H; Hashmi A; Fatima N
    J Coll Physicians Surg Pak; 2009 Mar; 19(3):173-8. PubMed ID: 19268018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors.
    Kostakoglu L; Elahi N; Kïratlï P; Ruacan S; Sayek I; Baltalï E; Sungur A; Hayran M; Bekdik CF
    J Nucl Med; 1997 Jul; 38(7):1003-8. PubMed ID: 9225779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.
    Maini CL; Tofani A; Sciuto R; Semprebene A; Cavaliere R; Mottolese M; Benevolo M; Ferranti F; Grandinetti ML; Vici P; Lopez M; Botti C
    J Nucl Med; 1997 Oct; 38(10):1546-51. PubMed ID: 9379190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between uptake of 99Tcm-MIBI and expression of multidrug resistant protein in breast cancer].
    Zhang XM; Zhang ZW; Wu H
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):353-5. PubMed ID: 15312346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.
    Ciarmiello A; Del Vecchio S; Silvestro P; Potena MI; Carriero MV; Thomas R; Botti G; D'Aiuto G; Salvatore M
    J Clin Oncol; 1998 May; 16(5):1677-83. PubMed ID: 9586878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of 201Tl and 99mTc-MIBI in breast tumor].
    Fukumitsu N; Tozaki M; Uchiyama M; Mori Y; Kawakami K; Uchida K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Nov; 56(13):974-9. PubMed ID: 8969062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer.
    Kostakoglu L; Kiratli P; Ruacan S; Hayran M; Emri S; Ergün EL; Bekdik CF
    J Nucl Med; 1998 Feb; 39(2):228-34. PubMed ID: 9476923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.
    Papantoniou VJ; Souvatzoglou MA; Valotassiou VJ; Louvrou AN; Ambela C; Koutsikos J; Lazaris D; Christodoulidou JK; Sotiropoulou MG; Melissinou MJ; Perperoglou A; Tsiouris S; Zerva CJ
    Breast Cancer Res; 2004; 6(2):R56-62. PubMed ID: 14979918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.